首页> 外文期刊>Medical Hypothesis, Discovery & Innovation Ophthalmology Journal >Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy
【24h】

Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy

机译:氩激光和小剂量乙酰水杨酸联合治疗急性中心性浆液性脉络膜视网膜病变

获取原文
           

摘要

This study was designed to evaluate the efficacy of low-dose of oral acetylsalicylic acid (aspirin) with focal argon laser for the treatment of acute central serous chorioretinopathy (CSCR). In this prospective case-control study, 40 Patients with acute CSCR were classified randomly to two groups; group A with no treatment as the control group and group B with argon Laser in focal treatment once, followed by aspirin, 100 mg per day orally, with follow up period of 12 months by evaluation of visual acuity, and by Optical Coherence Tomography (OCT) every three months for one year. Patients in second group treated with argon Laser and aspirin showed more clinically significant improvement in both visual acuity and OCT macular thickness by the end of follow up period when compared with the observational group. It was concluded that argon Laser with low-dose oral aspirin results in improvement of visual acuity and OCT macular thickness.
机译:这项研究旨在评估低剂量口服乙酰水杨酸(阿司匹林)与聚焦氩激光治疗急性中枢性浆液性脉络膜视网膜病变(CSCR)的疗效。在这项前瞻性病例对照研究中,将40例急性CSCR患者随机分为两组。 A组未进行对照组治疗,B组进行了一次氩激光聚焦治疗,然后口服阿司匹林,每天100 mg,通过视力评估和光学相干断层扫描(OCT)随访12个月),每三年三个月。与观察组相比,第二组接受氩激光和阿司匹林治疗的患者到随访期结束时,视力和OCT黄斑厚度均在临床上有更大的改善。结论是,低剂量口服阿司匹林的氩激光可改善视敏度和OCT黄斑厚度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号